Pharma CEOs

JPM18: GSK's Walmsley weighs in on Pfizer, gender diversity
JPM18: GSK's Walmsley weighs in on Pfizer, gender diversity
Biopharma Dive
GSK
Emma Walmsley
Pfizer
Pharma CEOs
gender diversity
JPMHC 2018
Flag link:
J&J chief Gorksy bullish on tax reform, plans $16B in repatriated overseas cash
J&J chief Gorksy bullish on tax reform, plans $16B in repatriated overseas cash
Mass Device
tax reform
JNJ
Pharma CEOs
Alex Gorsky
M&A
Flag link:
5 Things Amgen's CEO Just Said That Investors Need to Know
5 Things Amgen's CEO Just Said That Investors Need to Know
Motley Fool
Amgen
Pharma CEOs
Bob Bradway
Prolia
M&A
Flag link:
Drug pricing pressure isn't likely to get worse: Merck CEO
Drug pricing pressure isn't likely to get worse: Merck CEO
Fierce Pharma
drug pricing
Merck
Kenneth Frazier
Pharma CEOs
JPMHC 2018
Flag link:
Don't expect Restasis generics till at least next quarter, Allergan CEO says
Don't expect Restasis generics till at least next quarter, Allergan CEO says
Fierce Pharma
Allergan
Pharma CEOs
Brent Saunders
Restasis
generics
JPMHC 2018
Flag link:
[video]Eli Lilly CEO: It's a great time for science in pharma sector
[video]Eli Lilly CEO: It's a great time for science in pharma sector
Yahoo/CNBC
Eli Lilly
Pharma CEOs
David Ricks
JPMHC 2018
Flag link:
Men named Michael outnumber female CEOs presenting at #JPM18
Men named Michael outnumber female CEOs presenting at #JPM18
Stat
JPMHC 2018
Female Executives
Pharma CEOs
Flag link:
Novartis Pharma Ex-CEO takes three roles in two days
Novartis Pharma Ex-CEO takes three roles in two days
Pharmafile
Novartis
Pharma CEOs
David Epstein
Axcella Health
Rubius
Flag link:
Time for weighing things up for Kare Schultz, Teva CEO: group gains $8bn in capitalization in two months
Time for weighing things up for Kare Schultz, Teva CEO: group gains $8bn in capitalization in two months
GoinPharma
Teva Pharmaceutical
Pharma CEOs
Kåre Schultz
Flag link:
P&G investors wish for CEO Joe Jimenez as outgoing Novartis chief joins board
P&G investors wish for CEO Joe Jimenez as outgoing Novartis chief joins board
Fierce Pharma
P&G
Novartis
Pharma CEOs
Joe Jimenez
Flag link:
Teva's new launches won't feel the sting of hefty cost cuts: CEO
Teva's new launches won't feel the sting of hefty cost cuts: CEO
Fierce Pharma
Teva Pharmaceutical
drug launches
Pharma CEOs
Kåre Schultz
layoffs
Austedo
fremanezumab
Flag link:
Amicus CEO directly lobbied FDA’s Gottlieb to reverse FDA’s rejection of migalastat, claiming a delay of up to 7 years
Amicus CEO directly lobbied FDA’s Gottlieb to reverse FDA’s rejection of migalastat, claiming a delay of up to 7 years
Endpoints
Amicus
Pharma CEOs
FDA
Scott Gottlieb
migalastat
Fabry disease
Flag link:
Shire CEO: Hemophilia will remain a core business
Shire CEO: Hemophilia will remain a core business
BioPharma Dive
Shire
Pharma CEOs
hemophilia
Flemming Ornskov
Flag link:
Chris Weber, Takeda CEO, interviewed on his managerial style and Takeda’s pipeline
Chris Weber, Takeda CEO, interviewed on his managerial style and Takeda’s pipeline
GoinPharma
Chris Weber
Takeda
Pharma CEOs
Flag link:
Executive of the Year: Kenneth Frazier
Executive of the Year: Kenneth Frazier
BioPharma Dive
Merck
Pharma CEOs
Kenneth Frazier
Flag link:
Regeneron CEO Schleifer, a year after public Pfizer spat, slams Allergan for tribal deal
Regeneron CEO Schleifer, a year after public Pfizer spat, slams Allergan for tribal deal
Fierce Pharma
Regeneron
Allergan
Pharma CEOs
Leonard Schleifer
Pfizer
patents
Restasis
Flag link:
Incoming Novartis CEO On $475,000 Cancer Therapy: 'No Question That The List Price Raises Eyebrows'
Incoming Novartis CEO On $475,000 Cancer Therapy: 'No Question That The List Price Raises Eyebrows'
Forbes
Novartis
drug pricing
cancer
Kymriah
Pharma CEOs
Vas Narasimhan
Flag link:
Roiled by financial turmoil, Teva’s CEO boots R&D chief, top execs in C-suite overhaul
Roiled by financial turmoil, Teva’s CEO boots R&D chief, top execs in C-suite overhaul
Endpoints
Teva Pharmaceutical
Pharma CEOs
Kåre Schultz
R&D
executives
Flag link:
What to expect from Vas Narasimhan, next Novartis CEO
What to expect from Vas Narasimhan, next Novartis CEO
GoinPharma
Novartis
Pharma CEOs
Vas Narasimhan
Flag link:
Pfizer unveils plan to replace Ian Read
Pfizer unveils plan to replace Ian Read
GoinPharma
Pfizer
Pharma CEOs
Ian Read
Albert Bourla
Flag link:

Pages